ATE423321T1 - Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika - Google Patents

Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika

Info

Publication number
ATE423321T1
ATE423321T1 AT03799681T AT03799681T ATE423321T1 AT E423321 T1 ATE423321 T1 AT E423321T1 AT 03799681 T AT03799681 T AT 03799681T AT 03799681 T AT03799681 T AT 03799681T AT E423321 T1 ATE423321 T1 AT E423321T1
Authority
AT
Austria
Prior art keywords
prpsc
group
aminoglycoside antibiotics
detecting
diagnosing
Prior art date
Application number
AT03799681T
Other languages
English (en)
Inventor
Aly Moussa
Anthony Coleman
Reynier Anna Bencsik
Patrick Shahgaldian
Herve Perron
Ambroise Martin
Original Assignee
Afssa
Centre Nat Rech Scient
Univ Claude Bernard Lyon
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afssa, Centre Nat Rech Scient, Univ Claude Bernard Lyon, Biomerieux Sa filed Critical Afssa
Application granted granted Critical
Publication of ATE423321T1 publication Critical patent/ATE423321T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
AT03799681T 2002-12-20 2003-12-19 Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika ATE423321T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0216382A FR2849204B1 (fr) 2002-12-20 2002-12-20 Procede de detection de la prpsc utilisant un antibiotique d de la famille des aminoglycosides pour l'elimination et la detection de la prpsc dans des echantillons biologiques

Publications (1)

Publication Number Publication Date
ATE423321T1 true ATE423321T1 (de) 2009-03-15

Family

ID=32406304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799681T ATE423321T1 (de) 2002-12-20 2003-12-19 Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika

Country Status (12)

Country Link
US (1) US7695918B2 (de)
EP (1) EP1573336B1 (de)
JP (1) JP4471844B2 (de)
CN (1) CN1729396A (de)
AT (1) ATE423321T1 (de)
AU (1) AU2003299389A1 (de)
BR (1) BR0317224A (de)
DE (1) DE60326269D1 (de)
ES (1) ES2322704T3 (de)
FR (1) FR2849204B1 (de)
MX (1) MXPA05006765A (de)
WO (1) WO2004059321A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2888937B1 (fr) * 2005-07-21 2012-10-26 Biomerieux Sa Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
US7325983B1 (en) * 2006-08-25 2008-02-05 Emcore Corporation 10GBASE-LX4 optical transceiver in XFP package
MX355598B (es) * 2011-11-21 2018-04-24 Innovation Hammer Llc Metodos y sistemas para desarrollar plantas usando sustratos basados en silicato, cultivo de productividad fotosintetica mejorada y fotoproteccion mediante la utilizacion de glicopiranosidos exogenos para derivados de glicopiranosil-protein a endogenos, y formulaciones, procesos y sistemas para los mismos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993544A (en) * 1975-01-20 1976-11-23 Massachusetts Institute Of Technology Derivatives of streptomycin and method of producing streptomycin derivatives by mutational biosynthesis
EP0861900A1 (de) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunologischer Nachweis von Prionen
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6322802B1 (en) * 1999-06-01 2001-11-27 The Regents Of The University Of California Method of sterilizing
AU7365298A (en) 1997-05-02 1998-11-27 Integrated Research Technology, Llc Betaines as adjudvants to susceptibility testing and antimicrobial thera py
CA2385743A1 (en) * 1999-09-28 2001-04-05 Universitat Zurich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
IL150925A0 (en) 2000-02-01 2003-02-12 Little Inc A Chemical and/or biological decontamination system
IL141950A0 (en) * 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
CA2858543A1 (en) 2013-08-12 2015-02-12 GKart Inc. Amusement vehicle, amusement environment for a vehicle and method of using the same

Also Published As

Publication number Publication date
AU2003299389A8 (en) 2004-07-22
JP4471844B2 (ja) 2010-06-02
CN1729396A (zh) 2006-02-01
WO2004059321A8 (fr) 2005-06-30
AU2003299389A1 (en) 2004-07-22
BR0317224A (pt) 2005-11-01
MXPA05006765A (es) 2006-02-17
JP2006510913A (ja) 2006-03-30
FR2849204A1 (fr) 2004-06-25
US20060014215A1 (en) 2006-01-19
US7695918B2 (en) 2010-04-13
EP1573336B1 (de) 2009-02-18
WO2004059321A1 (fr) 2004-07-15
DE60326269D1 (de) 2009-04-02
ES2322704T3 (es) 2009-06-25
EP1573336A1 (de) 2005-09-14
FR2849204B1 (fr) 2005-02-11

Similar Documents

Publication Publication Date Title
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
WO2003070894A3 (en) A non-invasive diagnostic test utilizing histone modification markers
WO2004058044A3 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
ATE502119T1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
ATE538809T1 (de) Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff
ATE414149T1 (de) Survivin, ein protein das zelluläre apoptosis hemmt, und dessen modulation
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
EP2503338A3 (de) CD73 als Biomarker zur Überwachung der Entwicklung von Krankheiten und zum Testen der Wirksamkeit von Therapien
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
DE60318987D1 (de) Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen
ATE258310T1 (de) Testverfahren für collagenpeptid
DK0871457T3 (da) Isolerede stromaceller og fremgangsmåder til anvendelse heraf
DK0507831T3 (da) Fremgangsmåde til detektion af knogle- og bindevævssygdomme hos mennesker og dyr
DE60326269D1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
ATE354095T1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
BR0111975A (pt) Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
ATE406579T1 (de) Verfahren zur diagnose von tumoren
DE502004012230D1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
DE50303798D1 (de) Vorrichtung, um in einem Zielgebiet eines menschlichen oder tierischen Körpers einen künstlichen isolierten Kreislauf zu etablieren
DE60325725D1 (de) Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties